Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model

Journal of Applied Toxicology

Volumn 20, Issue SUPPL. 1, 2000, Pages

  Kadar, T ^a   Fishbeine, E ^a   Meshulam, Y ^a   Sahar, R ^a   Chapman, S ^a   Liani, H ^a   Harness, I ^a   Amir, A ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Local anaesthetics; Morphometry; Sulfur mustard; Vesicants

Indexed keywords

CALMODULIN; DERMATOLOGICAL AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MUSTARD GAS; OXYBUPROCAINE; PROCAINE; THIORIDAZINE; TRIFLUOPERAZINE;

ANIMAL; ARTICLE; BLISTER; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; FEMALE; INTRADERMAL DRUG ADMINISTRATION; SWINE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; ANIMALS; BLISTER; CALMODULIN; DERMATOLOGIC AGENTS; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; FEMALE; INJECTIONS, INTRADERMAL; LIDOCAINE; MUSTARD GAS; PROCAINE; SWINE; THIORIDAZINE; TRIFLUOPERAZINE;

EID: 0034570328     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1263(200012)20:1+<::aid-jat668>3.0.co;2-a     Document Type: Article

References (13)

1. Kim YB, Hur GH, Choi DS, Shin S, Han BG, Lee YS, Sok DE. Effects of calmodulin antagonists and anesthetics on the skin lesions induced by 2-chloroethylethyl sulfide. Eur. J. Pharmacol. 1996; 313: 107-114.
2. Beitner R, Chen-Zion M, Sofer-Bassukevitz Y, Oster Y, Ben Porat H, Motgenstern H. Therapeutic and prophylactic treatment of skin burns with several calmodulin antagonists. Gen. Pharmacol. 1989; 20: 165-173.
3. Ray R, Legere RH, Majerus BJ, Petrali JP. Sulfur mustard-induced increase in intracellular free calcium level and arachidonic acid release from cell membrane. Toxicol. Appl. Pharmacol. 1995; 131: 44-52.
4. Ray R, Legere RH, Broomfield CA, Petrali JP. Membrane alterations due to alkylating agents. Pharmacologist 1992; 34: 174.
5. 2+]; rise and time-dependent inhibition of B77 fibroblast serum response. J. Appl. Toxicol. 1993; 13: 161-168.
6. Mitcheltree LW, Mershon MM, Wall HG, Pulliam JD, Manthei JH. Microblister formation in vesicant-exposed pig skin. J. Toxicol. Ocul. Toxicol. 1989; 8: 309-319.
7. Wollina U, Berger U, Mahrle G. Immunohistochemistry of porcine skin. Acta Histochem. 1991; 90: 87-91.
8. Smith KJ, Skelton HG, Hobson DW, Reid FM, Blank JA, Hurst CG. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard. Am. J. Dermatopathol. 1996; 18: 515-520.
9. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical Defence against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. CRC Press: Boston, 1991; 1-359.
10. Ray R, Benton BJ, Anderson DR, Byers SL, Shih ML, Petrali JP. The intracellular free calcium chelator BAPTA prevents sulfur mustard toxicity in cultured normal human epidermal keratinocytes. Proc. Med. Defence Biosci. Rev. 1996; 2: 1021-1027.
11. Bhat KR, Benton BJ, Ray R. Studies on DNA ligase in human skin cells exposed to sulfur mustard. Proc. Med. Defence Biosci. Rev. 1996; 2: 767-776.
12. Beitner R, Chen-Zion M, Bassukevitz Y. Effect of the calmodulin antagonist CGS 9343B on skin burns. Gen. Pharmacol. 1991; 22: 67-72.
13. Cowan FM, Broomfield CA. Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol. Toxicol. 1993; 9: 201-214.